ERG’s role as a transcriptional repressor of cell differentiation was previously identified in prostate cancer, where aberrant expression of ERG inhibits the normal androgen receptor (AR) signaling pathway in coordination with transcriptional repression complexes55. This evidence concerns the gene AR and prostate carcinoma.